[Parkinson's Disease in the Oldest-Old].

Area of Science:

• Neurology
• Geriatrics
• Pharmacology

Background:

• Global increase in Parkinson's disease (PD) prevalence, particularly in older adults.
• Older age at PD onset correlates with increased symptom severity and faster progression.
• Comorbidities in older patients complicate PD diagnosis and treatment.

Purpose of the Study:

• To highlight the unique challenges of diagnosing and treating Parkinson's disease in older populations.
• To address the limited efficacy of L-dopa and the increased risk of specific complications in elderly PD patients.
• To emphasize the need for age-specific clinical trial data for PD medications.

Main Methods:

• Review of existing literature on Parkinson's disease in aging populations.
• Analysis of age-related differences in symptom presentation and disease progression.
• Examination of medication efficacy and complication risks in older PD patients.

Main Results:

• Older PD patients exhibit more severe motor and non-motor symptoms at diagnosis.
• L-dopa response is often limited in the elderly, with increased risks of axial symptoms, hallucinations, and dementia.
• Current PD medication evidence largely excludes older adults, necessitating new research.

Conclusions:

• Parkinson's disease presents distinct challenges in older adults due to comorbidities and altered medication responses.
• Age-specific research is crucial to develop effective treatment strategies for elderly Parkinson's patients.
• Future clinical trials must include older populations to ensure medication relevance and safety.